Computer Motion Interviewed on WallStreetReporter.com; CEO Bob Duggan Discusses the Life-Enhancing Technology and Business Strategy.Business Editors & High-Tech/Health/Medical Writers SANTA BARBARA, Calif.--(BUSINESS WIRE)--June 6, 2000 Computer Motion Inc. (Nasdaq:RBOT RBOT Rotating Bomb Oxidation Test ), the leader in medical robotics, today announced that its chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Robert W. Duggan, was featured in an interview on Monday, June 5, 2000, with the online financial forum WallStreetReporter.com. This interview can be heard at www.wallstreetreporter.com and will be archived until Friday, June 9, 2000. This is part of the company's continuing efforts to reinforce its product and market strategy, increase public exposure and increase shareholder value. The interview covers various aspects of the Computer Motion business strategy, strategic alliances, market expansion and broad-based clinical applications. Interview highlights include the recently launched Evolve(TM) Cardiac Continuum, a systematic and economical pathway for surgeons and institutions to advance their minimally invasive cardiac program and to deliver improved patient outcomes. Computer Motion, the world leader in medical robotics, is creating the cornerstone technologies and products for the Intelligent Operating Room(TM). The company develops, manufactures and markets proprietary computer-enhanced and robotic surgical systems, which enhance surgeons' capabilities, improve outcomes and reduce costs. Computer Motion's products include the voice-controlled AESOP Aesop (ē`səp, ē`sŏp), legendary Greek fabulist. According to Herodotus, he was a slave who lived in Samos in the 6th cent. B.C. and eventually was freed by his master. (R) endoscope positioning system; the HERMES(TM) Control Center, a centralized system which enables the surgeon to voice control a network of "smart" medical devices; and the ZEUS(TM) Robotic Surgical System for new minimally invasive microsurgery microsurgery or micromanipulation Surgical technique for operating on minute structures, with specialized, tiny precision instruments under observation through a microscope, sometimes equipped with cameras to show the operation on a monitor. procedures, such as endoscopic coronary artery bypass grafting (E-CABG(TM)). ZEUS is CE-Marked for commercial sale in the European Community, and the company has completed an FDA-approved Phase 1 Investigational Device Exemption An Investigational Device Exemption (IDE) allows the investigational device to be used in a clinical study in order to collect safety and effectiveness data required to support a Premarket Approval (PMA) application or a Premarket Notification [510(k)] submission to Food and (IDE) coronary bypass study and has initiated an IDE mitral valve surgery study with ZEUS. Computer Motion and Medtronic (NYSE NYSE See: New York Stock Exchange :MDT MDT abbr. Mountain Daylight Time MDT (in the US and Canada) Mountain Daylight Time MDT n abbr (US) (= mountain daylight time) → ) are co-marketing ZEUS. The company's Web site is www.ComputerMotion.com. |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion